Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Neutral

Analyst Rating

Sell

Simple Moving Average

Sell

Exponential Moving Average

Sell

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Lifecore Biomedical, Inc. Common Stock (LFCR)

Pharmaceutical Preparations

https://www.lifecore.com

Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid.

3515 LYMAN BOULEVARD
CHASKA, MN

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

02/15/1996

Market Cap

179,720,306

Shares Outstanding

30,320,000

Weighted SO

29,513,000

Total Employees

N/A

Upcoming Earnings

08/29/2024

Similar Tickers

MNK --.--%

LSDI --.--%

ALIM --.--%

ADMP --.--%

SHPH --.--%

CTLT --.--%

TLRY --.--%

KMDA --.--%

CPIX --.--%

Beta

0.9700

Last Div

0.0000

Range

4.47-9.58

Chg

-0.1581

Avg Vol

226985

Mkt Cap

179720306

Exch

NASDAQ

Country

US

Phone

952 368 4300

DCF Diff

11.0738

DCF

-5.2038

Div Yield

0.0000

P/S

1.4741

EV Multiple

-78.4961

P/FV

2.9865

Div Yield %

0.0000

P/E

-10.4202

PEG

0.0879

Payout

-0.0439

Current Ratio

2.0689

Quick Ratio

0.9912

Cash Ratio

0.0835

DSO

94.1374

DIO

162.7794

Op Cycle

256.9168

DPO

64.3608

CCC

192.5560

Gross Margin

0.2704

Op Margin

-0.1238

Pretax Margin

-0.1387

Net Margin

-0.1397

Eff Tax Rate

-0.0274

ROA

-0.0692

ROE

-0.5387

ROCE

-0.0721

NI/EBT

1.0070

EBT/EBIT

1.1202

EBIT/Rev

-0.1238

Debt Ratio

0.4921

D/E

2.0389

LT Debt/Cap

0.6617

Total Debt/Cap

0.6709

Int Coverage

-0.9005

CF/Debt

-0.2168

Equity Multi

4.1431

Rec Turnover

3.8773

Pay Turnover

5.6712

Inv Turnover

2.2423

FA Turnover

0.8245

Asset Turnover

0.4951

OCF/Share

-0.8617

FCF/Share

-1.6399

Cash/Share

0.1008

OCF/Sales

-0.2155

FCF/OCF

1.9032

CF Coverage

-0.2168

ST Coverage

-5.3264

CapEx Coverage

-1.1071

Div&CapEx Cov

-1.0733

P/BV

2.9865

P/B

2.9865

P/S

1.4741

P/E

-10.4202

P/FCF

-3.5945

P/OCF

-6.7567

P/CF

-6.7567

PEG

0.0879

P/S

1.4741

EV Multiple

-78.4961

P/FV

2.9865

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Jan 17, 22:24 Lifecore Biomedical Announces Special Stockholder Meeting GlobeNewswire Inc. Oct 16, 04:00 Hyaluronic Acid Market Driven by Increasing Demand for Cosmetics and Expected to Grow over 21 Bn by 2032 GlobeNewswire Inc. Sep 27, 00:15 LFCR DEADLINE TOMORROW: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Lifecore Biomedical, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important September 27 Deadline in Securities Class Action – LFCR GlobeNewswire Inc. Sep 23, 22:10 LFCR FINAL DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Lifecore Biomedical, Inc. Investors to Secure Counsel Before Important September 27 Deadline in Securities Class Action – LFCR GlobeNewswire Inc. Sep 17, 00:09 LFCR DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Lifecore Biomedical, Inc. Investors to Secure Counsel Before Important September 27 Deadline in Securities Class Action – LFCR GlobeNewswire Inc. Sep 05, 22:36 Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Lifecore Biomedical, Inc. (LFCR) GlobeNewswire Inc. Aug 23, 22:25 Pending Lead Plaintiff Deadline in the LFCR Class Action: Robbins LLP Reminds Stockholders With Large Losses of Lifecore Biomedical, Inc. to Seek Counsel GlobeNewswire Inc. Aug 23, 00:15 ROSEN, LEADING INVESTOR COUNSEL, Encourages Lifecore Biomedical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – LFCR GlobeNewswire Inc. Aug 19, 04:03 Shareholder Rights Law Firm Robbins LLP Urges LFCR Stockholders to Contact the Firm for Information About the Lifecore Biomedical, Inc. Class Action GlobeNewswire Inc. Aug 18, 16:54 ROSEN, LEADING TRIAL ATTORNEYS, Encourages Lifecore Biomedical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – LFCR GlobeNewswire Inc. Aug 18, 01:00 Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lifecore, Seritage, Oddity Tech, and Arbor Realty and Encourages Investors to Contact the Firm GlobeNewswire Inc. Aug 15, 00:44 ROSEN, A LEADING NATIONAL FIRM, Encourages Lifecore Biomedical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – LFCR GlobeNewswire Inc. Aug 09, 21:34 ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Lifecore Biomedical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – LFCR GlobeNewswire Inc. Aug 09, 20:45 Poulin I Willey I Anastopoulo Announces A Class Action Lawsuit Has Been Filed Against Lifecore Biomedical, Inc. (LFCR) GlobeNewswire Inc. Aug 05, 01:00 Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lifecore, Seritage, Oddity Tech, and Arbor Realty and Encourages Investors to Contact the Firm GlobeNewswire Inc. Jan 12, 16:43 Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report GlobeNewswire Inc. Jan 12, 16:43 Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report GlobeNewswire Inc. Dec 13, 07:30 Lifecore Biomedical Provides Business Update

Revenue Product Segmentation